CL2004000754A1 - Uso de compuestos derivados de 4-fenil-4-(1h-imidazol-2-il)piperidina, como agonistas delta-opioides no peptidicos, para preparar un medicamento util en prevenir o tratar trastornos del sistema nervioso central. - Google Patents
Uso de compuestos derivados de 4-fenil-4-(1h-imidazol-2-il)piperidina, como agonistas delta-opioides no peptidicos, para preparar un medicamento util en prevenir o tratar trastornos del sistema nervioso central.Info
- Publication number
- CL2004000754A1 CL2004000754A1 CL200400754A CL2004000754A CL2004000754A1 CL 2004000754 A1 CL2004000754 A1 CL 2004000754A1 CL 200400754 A CL200400754 A CL 200400754A CL 2004000754 A CL2004000754 A CL 2004000754A CL 2004000754 A1 CL2004000754 A1 CL 2004000754A1
- Authority
- CL
- Chile
- Prior art keywords
- imidazol
- piperidine
- phenyl
- prepare
- prevent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP0303879 | 2003-04-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2004000754A1 true CL2004000754A1 (es) | 2005-02-25 |
Family
ID=33154992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL200400754A CL2004000754A1 (es) | 2003-04-11 | 2004-04-07 | Uso de compuestos derivados de 4-fenil-4-(1h-imidazol-2-il)piperidina, como agonistas delta-opioides no peptidicos, para preparar un medicamento util en prevenir o tratar trastornos del sistema nervioso central. |
Country Status (12)
Country | Link |
---|---|
US (1) | US20060287345A1 (es) |
EP (1) | EP1615644B1 (es) |
JP (1) | JP2006522775A (es) |
AR (1) | AR044010A1 (es) |
AT (1) | ATE353649T1 (es) |
AU (1) | AU2004228960A1 (es) |
CA (1) | CA2521186A1 (es) |
CL (1) | CL2004000754A1 (es) |
DE (1) | DE602004004771T2 (es) |
ES (1) | ES2282858T3 (es) |
TW (1) | TW200509913A (es) |
WO (1) | WO2004089372A1 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1390848B1 (it) | 2008-07-31 | 2011-10-19 | Neuroscienze Pharmaness S C A R L | Composti farmaceutici |
EP2149370A1 (en) | 2008-07-31 | 2010-02-03 | Neuroscienze Pharmaness S.C. A R.L. | Diazabicyclic compounds and microemulsions thereof |
JP2011030565A (ja) * | 2009-07-06 | 2011-02-17 | Yokohama City Univ | 社会的隔離モデル動物 |
IT1396951B1 (it) | 2009-12-18 | 2012-12-20 | Neuroscienze Pharmaness S C A R L | Composti farmaceutici |
CA2911231C (en) * | 2013-05-24 | 2021-12-07 | Alkermes Pharma Ireland Limited | Morphan and morphinan analogues, and methods of use |
HUE057266T2 (hu) | 2015-03-17 | 2022-05-28 | Nippon Chemiphar Co | Morfinán származék |
US20210371422A1 (en) | 2016-08-09 | 2021-12-02 | Nippon Chemiphar Co., Ltd. | Morphinan derivative |
CN110248658B (zh) | 2016-09-16 | 2023-10-13 | 日本化学药品株式会社 | 吗啡喃衍生物的在阿片δ受体激动剂相关疾病的治疗中的应用 |
PE20210052A1 (es) | 2018-05-01 | 2021-01-08 | Merck Sharp & Dohme | Moduladores alostericos de espiropiperidina de receptores nicotinicos de acetilcolina |
AU2020385852A1 (en) | 2019-11-22 | 2022-06-02 | Nippon Chemiphar Co., Ltd. | Pyrazolomorphinan derivative |
WO2022181763A1 (ja) | 2021-02-26 | 2022-09-01 | 学校法人東京理科大学 | ストレス関連障害の治療又は予防用医薬組成物 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5354863A (en) * | 1992-01-21 | 1994-10-11 | G. D. Searle & Co. | Opioid agonist compounds |
DE19805370A1 (de) * | 1997-03-14 | 1998-09-17 | Gruenenthal Gmbh | Substituierte Aminoverbindungen und ihre Verwendung als analgetisch wirksame Substanzen |
HN1999000149A (es) * | 1998-09-09 | 2000-01-12 | Pfizer Prod Inc | Derivados de 4,4-biarilpiperidina |
EP1038872A1 (en) * | 1999-02-22 | 2000-09-27 | Pfizer Products Inc. | 4-Phenyl-4-heteroarylpiperdine derivatives as opioid receptor ligands |
DE19939044A1 (de) * | 1999-08-18 | 2001-03-15 | Gruenenthal Gmbh | Verwendung von Morphinanderivaten als Arzneimittel |
SE0101767D0 (sv) * | 2001-05-18 | 2001-05-18 | Astrazeneca Ab | Novel compounds |
AU2002363369B2 (en) * | 2001-10-15 | 2008-08-21 | Janssen Pharmaceutica N.V. | Substituted 4-phenyl-4-(1H-imidazol-2-yl)-piperidine derivatives for reducing ischaemic damage |
KR100898562B1 (ko) * | 2001-10-15 | 2009-05-20 | 얀센 파마슈티카 엔.브이. | 신규 치환된 4-페닐-4-[1h-이미다졸-2-일]-피페리딘유도체 및 선택적인 비펩타이드 델타 아편유사작용제로서의 그의 용도 |
-
2004
- 2004-04-07 AR ARP040101193A patent/AR044010A1/es not_active Application Discontinuation
- 2004-04-07 CL CL200400754A patent/CL2004000754A1/es unknown
- 2004-04-08 DE DE602004004771T patent/DE602004004771T2/de not_active Expired - Fee Related
- 2004-04-08 US US10/552,527 patent/US20060287345A1/en active Pending
- 2004-04-08 AU AU2004228960A patent/AU2004228960A1/en not_active Abandoned
- 2004-04-08 JP JP2006505540A patent/JP2006522775A/ja not_active Withdrawn
- 2004-04-08 EP EP04726520A patent/EP1615644B1/en not_active Expired - Lifetime
- 2004-04-08 CA CA002521186A patent/CA2521186A1/en not_active Abandoned
- 2004-04-08 WO PCT/EP2004/050492 patent/WO2004089372A1/en active IP Right Grant
- 2004-04-08 ES ES04726520T patent/ES2282858T3/es not_active Expired - Lifetime
- 2004-04-08 AT AT04726520T patent/ATE353649T1/de not_active IP Right Cessation
- 2004-04-09 TW TW093109827A patent/TW200509913A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
AU2004228960A1 (en) | 2004-10-21 |
DE602004004771D1 (de) | 2007-03-29 |
EP1615644B1 (en) | 2007-02-14 |
DE602004004771T2 (de) | 2007-12-06 |
AR044010A1 (es) | 2005-08-24 |
US20060287345A1 (en) | 2006-12-21 |
JP2006522775A (ja) | 2006-10-05 |
CA2521186A1 (en) | 2004-10-21 |
TW200509913A (en) | 2005-03-16 |
ES2282858T3 (es) | 2007-10-16 |
ATE353649T1 (de) | 2007-03-15 |
WO2004089372A1 (en) | 2004-10-21 |
EP1615644A1 (en) | 2006-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0517015A (pt) | compostos e composições como inibidores de atividade de receptor 1 de canabinóide | |
CL2007003049A1 (es) | Compuestos derivados de 2,4-diaminopirimidina; composicion farmaceutica, utiles para tratar trastornos proliferativos. | |
TW200732296A (en) | Novel compounds | |
ATE482209T1 (de) | Verbindungen und zusammensetzungen als modulatoren der gpr119-aktivität | |
EA201001329A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
JO2769B1 (en) | Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor | |
MX2009007944A (es) | Compuestos y composiciones de purina como inhibidores de quinasa para el tratamiento de enfermedades relacionadas con plasmodium. | |
SG170813A1 (en) | New compounds | |
BRPI0607529A2 (pt) | compostos de azol neuroterapêuticos | |
TN2010000122A1 (en) | Compounds and compositions as modulators of gpr119 activity | |
CL2011000478A1 (es) | Compuestos derivados de 2-imidazol-propanamida sustituidos, activadores de glucoquinasa; composicion farmaceutica, util para tratar o retrasar la progresion o aparacion de la diabetes tipo ii o trastornos relacionados con la diabetes. | |
CR8254A (es) | [1,8] naftidrin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia | |
CL2004000695A1 (es) | Compuestos derivados de 4-fenil piperidina, composicion farmaceutica, util como modulador del receptor opioides, para tratar sindrome de intestino irritable, adiccion o dependencia de drogas, depresion, ansiedad, esquizofrenia, trastornos de la alime | |
CY1115789T1 (el) | 2,3-διυδροβενζο[1,4]διοξιν-2-υλομεθυλο παραγωγα ως αλφα2c ανταγωνιστες για χρηση στη θεραπευτικη αγωγη παθησεων του περιφερικου και του κεντρικου νευρικου συστηματος | |
NO20084712L (no) | Nye farmasoytiske forbindelser | |
GT200600081A (es) | Derivados de acetilenno | |
EA201001330A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
CL2004000754A1 (es) | Uso de compuestos derivados de 4-fenil-4-(1h-imidazol-2-il)piperidina, como agonistas delta-opioides no peptidicos, para preparar un medicamento util en prevenir o tratar trastornos del sistema nervioso central. | |
WO2007108936A3 (en) | N-substituted-azacyclylamines as histamine-3 antagonists | |
WO2007136668A3 (en) | N-benzoyl-and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists | |
PL1853232T3 (pl) | Trwałe postaci krystaliczne mesylanu bifeprunoksu, postaci dawkowania oraz sposoby ich stosowania | |
JO2849B1 (en) | Dopamine 2 receptor antagonists are rapidly hydrolyzed | |
MX2009011999A (es) | Extruidos con enmascaramiento del sabor mejorado. | |
GB0525069D0 (en) | Organic compounds | |
JO2642B1 (en) | Dopamine 2 receptor antagonists are rapidly hydrolyzed |